Immunostaining of podocyte associate markers in renal biopsies; a valuable adjunct in characterisation of podocytopathies

Abstract Introduction: Glomerular diseases comprise a wide spectrum of histopathological appearances within a clinically defined diagnosis of nephrotic syndrome (NS). Many of glomerular diseases are the result of genetic mutations encoding podocytic markers. Objective: Our aim in this study was to offer a framework that integrates renal morphology with podocytopathies to facilitate management strategies and prognostic information. Materials and Methods: Descriptive study of 50 cases of NS along with 50 controls wherein a combination of histopathological examination, morphometric studies, immunohistochemistry, direct and indirect immunofluorescence (IFF) were employed for evaluation of podocyte markers (podocin and nephrin) in renal biopsies. The clinical and demographic profile, management received and follow up was recorded for each patient and correlated with renal biopsy. Results: All control renal tissues (n=50) exhibited linear glomerular basement membrane (GBM) staining. To maintain homogeneity we analyzed patients of minimal change disease (MCD), focal segmental glomerulosclerosis (FSGS), mesangial hypercellularity and diffuse mesangial sclerosis (DMS) and we grouped them as ‘podocytopathies’ (n=38). All cases (n=38) exhibited evidence of podocyte injury as evident by change of linear GBM positivity to granular pattern or complete absence of podocin (07/38, 14%)) or nephrin (3/38, 7.8%). No histopathological variable predicted clinical response (P=0.260). The integrated diagnosis formulated by incorporating glomerular morphology and podocyte molecular phenotype strongly correlated with steroid resistance and outcome. (χ2=26.437, P<0.001and χ2=25.73, P<0.001). Conclusion: Evaluating podocytopathies in a more systematic manner by incorporating podocyte markers in the work up will facilitate more planned approach to diagnosis and management. Key point Evaluating podocytopathies in a more systematic manner by incorporating podocyte markers in the work up will facilitate more planned approach to diagnosis and management. Citation Badwal S, Kumar A, Singh S, Dutta V. Immunostaining of podocyte associate markers in renal biopsies; a valuable adjunct in characterisation of podocytopathies. Immunopathol Persa. 2016;2(2):e19.

[1]  A. Anarat,et al.  Spectrum of steroid-resistant and congenital nephrotic syndrome in children: the PodoNet registry cohort. , 2015, Clinical journal of the American Society of Nephrology : CJASN.

[2]  A. Anarat,et al.  Genetic screening in adolescents with steroid-resistant nephrotic syndrome. , 2013, Kidney international.

[3]  L. Castellano,et al.  An Overview of Molecular Mechanism of Nephrotic Syndrome , 2012, International journal of nephrology.

[4]  R. Wiggins,et al.  The spectrum of podocytopathies: a unifying view of glomerular diseases. , 2007, Kidney international.

[5]  H. Schnaper,et al.  A proposed taxonomy for the podocytopathies: a reassessment of the primary nephrotic diseases. , 2007, Clinical journal of the American Society of Nephrology : CJASN.

[6]  A. Bakkaloğlu,et al.  Patients with mutations in NPHS2 (podocin) do not respond to standard steroid treatment of nephrotic syndrome. , 2004, Journal of the American Society of Nephrology : JASN.

[7]  H. Kawachi,et al.  Expression of podocyte-associated molecules in acquired human kidney diseases. , 2003, Journal of the American Society of Nephrology : JASN.

[8]  F. Scolari,et al.  Podocin mutations in sporadic focal-segmental glomerulosclerosis occurring in adulthood. , 2003, Kidney international.

[9]  G. Mazzucco,et al.  Broadening the spectrum of diseases related to podocin mutations. , 2003, Journal of the American Society of Nephrology : JASN.

[10]  Y. Frishberg,et al.  Mutations in NPHS2 encoding podocin are a prevalent cause of steroid-resistant nephrotic syndrome among Israeli-Arab children. , 2002, Journal of the American Society of Nephrology : JASN.

[11]  G. Ghiggeri,et al.  Prevalence, genetics, and clinical features of patients carrying podocin mutations in steroid-resistant nonfamilial focal segmental glomerulosclerosis. , 2001, Journal of the American Society of Nephrology : JASN.

[12]  R. Ferrell,et al.  Familial nephrotic syndrome: clinical spectrum and linkage to chromosome 19q13. , 2000, Kidney international.

[13]  A. Arteta,et al.  Nephrin, podocin and alpha-actinin-4 in renal tissue from patients with proteinuria , 2009 .

[14]  A. Arteta,et al.  [Expression of nephrin, podocin and a-actinine-4 in renal tissue of patients with proteinuria]. , 2009, Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia.